Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis

Journal of the American Society of Nephrology

Volumn 21, Issue 8, 2010, Pages 1361-1369

  Alves, Tahira P ^a   Wang, Xuelei ^b   Wright, Jackson T ^c   Appel, Lawrence J ^d   Greene, Tom ^e   Norris, Keith ^f   Lewis, Julia ^g  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^g VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; EDUCATION; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INCOME; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHROSCLEROSIS; PRIORITY JOURNAL; PROTEIN URINE LEVEL;

EID: 77955640881     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009060654     Document Type: Article

References (28)

1. US Renal Data System: USRDS 2007 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive Kidney Diseases, 2007
2. Keith D, Nichols G, Gullien C, Brown J, Smith D: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164: 659-663, 2004 (Pubitemid 38392981)
3. Sarnak M, Levey A, Schoolweth A, Coresh J, Culleton B, Hamm L, McCoullough P, Kasiske B, Kelepouris E, Klag M, Parfrey P, Pfeffer M, Raij L, Spinosa D, Wilson P: Kidney disease is a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 42: 1050-1065, 2003 (Pubitemid 37413751)
4. Foley R, Parfrey P, Sarnak M: Clinical epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Dis 32: S112-S119, 1998 (Pubitemid 28527268)
5. Go A, Chertow G, Fan D, Mcculloch C, Hsu C: Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization. N Engl J Med 351; 1296-1305, 2004
6. Brenner B, Cooper M, de Zeeuw D, Keane W, Mitch W, Remuzzi G, Snappinn S, Zhang Z, Shahinfar S: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345: 861-869, 2001
7. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA 288: 2981-2997, 2002
8. Rahman M, Pressel S, Davis B, Nwachuku C, Wright J, Whelton P, Barzilay J, Bahtman V, Eckfeldt J, Farber M, Henriquez M, Kopyt N, Louis G, Saklayen M, Stanford C, Walworth C, Ward H, Weigman T: Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic. Arch Intern Med 165: 936-946, 2005
9. Norris K, Agodoa L: Unraveling the racial disparities associated with kidney disease. Kidney Int 68: 914-924, 2005
10. Powe N: To have and have not: Health and health care disparities in chronic kidney disease. Kidney Int 64: 763-772, 2003
11. Agodoa L, Eggers P: Racial and ethnic disparities in end-stage kidney failure-survival paradoxes in African Americans. Semin Dial 20: 577-585, 2007
12. Weiner D, Tighiouart H, Amin M, Stark P, MacLeod B, Griffith J, Salem D, Levey A, Sarnak M: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol 15: 1307-1315, 2004
13. Mehrotra R, Kermah D, Fried L, Adler S, Norris K: Racial differences in mortality among those with chronic kidney disease. J Am Soc Nephrol 19: 1403-1410, 2008
14. Appel L, Bakris G, Gabbai J, Greene T, Kopple J, Lipkowitz M, Norris K, Rahman M, Rostand S, Schulman G, Wang X, Wright J, African-American Study of Kidney Disease and Hypertension Investigators: Progression of hypertensive chronic kidney disease is common among African Americans with excellent blood pressure control and high rates of use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Arch Intern Med 168: 832-839, 2008
15. Foley R, Murray A, Herzog C, McBean A, Eggers P, Collins A: Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 16: 489-495, 2005
16. Newsome BB, McClellan WM, Allison JJ, Eggers PW, Chen SC, Collins AJ, Kiefe CI, Coffey CS, Warnock DG: Racial differences in the competing risks of mortality and ESRD after acute myocardial infarction. Am J Kidney Dis 52: 251-261, 2008
17. O'Hare A, Choi A, Bertenthal D, Bacchetti P, Garg A, Kaufman J, Walter L, Mehta K, Steinman M, Allon M, McClellan W, Landefeld C: Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 18: 2758-2765, 2007 (Pubitemid 47531203)
18. Derose SF, Rutkowski MP, Levin NW, Liu IL, Shi JM, Jacobsen SJ, Crooks PW: Incidence of end-stage renal disease and death among insured African Americans with chronic kidney disease. Kidney Int 76: 629-637, 2009
19. Norris K, Bourgoigne J, Gassman J, Herbert L, Middleton J, Phillips R, Randall O, Rostand S, Shaper S, Toto R, Wright J, Wang X, Greene T, Appel L, Lewis J: Cardiovascular Outcomes in the African-American Study of Kidney Disease and Hypertension (AASK) Trial. Am J Kidney Dis 48: 739-751, 2006
20. Wright J, Bakris G, Greene T, Agodoa L, Appel L, Charleston J, Creek D, Douglas-Baltimore J, Gassman J, Glassock R, Herbert L, Jamerson K, Lewis J, Phillips R, Toto R, Middleton J, Rostand S: Design and baseline characteristics of participation in the African-American Study of Kidney Disease and Hypertension. Controlled Clinical Trials 16: 35-165, 1996
21. Gassman J, Greene T, Wright J, Agodoa L, Bakris G, Beck G, Douglas J, Jamerson K, Lewis J, Kutner M, Randall O, Wang S: Design and statistical aspects of African American Study of Kidney Disease and Hypertension. J Am Soc Nephrol 14: 5154-5165, 2003
22. Sika M, Lewis J, Douglas J, Erlinger T, Dowie D, Lipkowitz M, Lash J, Cornish-Zirker D, Peterson G, Toto R, Kusek J, Appel L, Kendrick C, Gassman J: Baseline characteristics in the African American Study of Kidney Disease and Hypertension (AASK) clinical trial and cohort study. Am J Kidney Dis 50: 78-89, 89.e1, 2007
23. Wright J, Bakris G, Greene T, Agodoa L, Appel L, Chertow J, Cheek D, Douglas-Baltimore J, Gassman J, Herbert L, Jamerson K, Lewis J, Phillips R, Toto R, Middleton J, Rostand S: The effects of blood pressure lowering class of anti-hypertensive therapy on progression of hypertensive kidney disease: Results from the AASK Trial. JAMA 288: 2421-2431, 2002
24. Agodoa L, Appel L, Bakris G, Beck G, Bourgoignie J, Briggs J, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple J, Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M, Massry S, Middleton J, Miller ER 3rd, Norris K, O'Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright JT Jr, Xu S, African American Study of Kidney Disease and Hypertension (AASK) Study Group: Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis. JAMA 285: 2719-2728, 2001
25. Appel L, Middleton L, Miller E 3rd, Lipkowitz M, Norris K, Agodoa L, Bakris G, Douglas J, Charleston J, Gassman J, Greene T, Jamerson K, Kusek J, Lewis J, Phillips R, Rostand G, Wright J: The rationale and design of the AASK cohort study. J Am Soc Nephrol 14[Suppl 2]: S166-S172, 2003
26. Lewis J, Agodoa L, Cheek D, Greene T, Middleton J, O'Connor D, Ojo A, Philips R, Sika M, Wright J: Comparison of cross-sectional renal function measurements in African-Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. Am J Kidney Dis 38: 744-775, 2001
27. Wang X, Lewis J, Appel L, Creek D, Contreras G, Faulkner M, Feldman H, Gassman J, Lea J, Kopple J, Sika M, Toto R, Greene T: Validation of creatinine-based estimated of GFR when evaluating risk factors in longitudinal studies of kidney disease. J Am Soc Nephrol 17: 2900-2909, 2006
28. Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16: 1141-1154, 1998